Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.64
+0.18000.66%
Pre-market: 27.640.00000.00%05:45 EDT
Volume:29.01M
Turnover:802.51M
Market Cap:157.15B
PE:36.37
High:27.81
Open:27.62
Low:27.55
Close:27.46
52wk High:29.21
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.97
T/O Rate:0.51%
Dividend:1.72
Dividend Rate:6.22%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.84
PE(LYR):20.26

Loading ...

Pfizer's experimental drug misses main goal of lung cancer trial

Reuters
·
Jun 23

Pfizer says sigvotatug vedotin did not show big improvement in primary endpoint

TIPRANKS
·
Jun 23

Pfizer says Phase 3 SigVie-002 trial misses overall survival endpoint for sigvotatug vedotin in metastatic NSCLC

Reuters
·
Jun 23

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

THOMSON REUTERS
·
Jun 23

Pfizer - Sigvotatug Vedotin Shows Manageable Safety Profile Consistent With Prior Studies

THOMSON REUTERS
·
Jun 23

Pfizer - Sigvotatug Vedotin Does Not Improve Overall Survival Versus Docetaxel in Phase 3 Study

THOMSON REUTERS
·
Jun 23

Pfizer - Stronger Trend for Os and Pfs With Sigvotatug Vedotin in Second-Line Nsclc Patients

THOMSON REUTERS
·
Jun 23

Pfizer - No Clear Ib6 Expression-Response Relationship Observed in Exploratory Analysis

THOMSON REUTERS
·
Jun 23

Asad Haider Reiterates Hold on PFE, Keeps 12-Month Price Target Unchanged at $26 Amid CFO Transition and Clinical Upside Uncertainty

TIPRANKS
·
Jun 21

Pfizer’s AI Upgrades and Pipeline Bets Stir Investor Hopes

TIPRANKS
·
Jun 20

Pfizer (PFE) Stock Could Be 10% Undervalued After CFO Exit Raises Execution Questions

Simply Wall St.
·
Jun 20

BRIEF-CMA Says Court Of Appeal Ruled Tribunal Was "Wrong To Set Aside [CMA's] Decision" In Relation To Investigation Into Phenytoin

Reuters
·
Jun 19

Regulator wins decade-long pricing tussle with Pfizer

cityam
·
Jun 19

NYSE Most Active Issues

Dow Jones
·
Jun 19

Pfizer Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 19

AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 19

Pfizer (PFE) Shares Sink After Surprise CFO Exit

TIPRANKS
·
Jun 19

Pfizer Shares Fall After Reaffirming Fiscal 2026 Guidance

MT Newswires Live
·
Jun 19

Pfizer Reaffirms 2026 Outlook Amid CFO Transition

TIPRANKS
·
Jun 19

Sector Update: Healthcare Stocks Decline Thursday Afternoon

MT Newswires Live
·
Jun 19